entity

2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about 2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
30Hypotheses
30Analyses
0Outgoing
2Incoming
7Experiments
20Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

PI-2620 Tau PET in PSP

clinical · 5625 words

Section 162: Advanced Antioxidant and Redox Therapy in CBS/PSP

therapeutic · 5600 words

HNRNPA2B1 Protein

protein · 5015 words

p-tau-217

biomarker · 4980 words

ncam2

gene · 4719 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (2)

SourceRelationTypeStr
h-e5f1182btargetshypothesis0.60
h-0bdc3803targetshypothesis0.55

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen 0.990 neurodegeneration Gene expression changes in aging mouse b
TREM2-Dependent Microglial Senescence Transition 0.950 neurodegeneration Gene expression changes in aging mouse b
PLCG2 Allosteric Modulation as a Precision Therapeutic for T 0.941 neurodegeneration TREM2 agonism vs antagonism in DAM micro
Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-00 0.938 molecular neurobiology View
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli 0.921 neurodegeneration Lipid raft composition changes in synapt
HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM 0.919 neurodegeneration How do different microglial subtypes (DA
TREM2-ASM Crosstalk in Microglial Lysosomal Senescence 0.910 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.907 neurodegeneration Gene expression changes in aging mouse b
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc 0.895 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener 0.892 neurodegeneration Gene expression changes in aging mouse b
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from 0.887 neurodegeneration How does APOE4's beneficial immune funct
TREM2-APOE Axis Dissociation for Selective DAM Activation 0.886 neurodegeneration TREM2 agonism vs antagonism in DAM micro
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.880 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.875 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Cholesterol Dysregulation in Microglial Senes 0.869 neurodegeneration Gene expression changes in aging mouse b
GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl 0.869 neuroscience Circuit-level neural dynamics in neurode
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 0.861 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima 0.858 neurodegeneration How do different microglial subtypes (DA
Microglial Senescence Prevention via TREM2/SASP Axis 0.847 neurodegeneration View
TYROBP (DAP12) Conditional Antagonism for Early-Stage Neurop 0.844 neurodegeneration TREM2 agonism vs antagonism in DAM micro
Neutral Sphingomyelinase-2 Inhibition for Synaptic Protectio 0.844 neurodegeneration Lipid raft composition changes in synapt
H6: Aberrant eIF2α Phosphorylation Creates Stalled Translati 0.834 neurodegeneration How do pathological stress granules tran
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 0.824 neurodegeneration What are the mechanisms by which gut mic
TREM2-Mediated Microglial Dysfunction Disrupts Perivascular 0.812 neuroscience Circuit-level neural dynamics in neurode
CSF1R-TREM2 Co-Agonism for Sustained Microglial Expansion 0.808 neurodegeneration TREM2 agonism vs antagonism in DAM micro
Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone 0.808 neurodegeneration What are the precise temporal dynamics o
P2RX7-Mediated Exosome Secretion Blockade 0.807 neurodegeneration Tau propagation mechanisms and therapeut
Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in N 0.805 neurodegeneration What are the mechanisms by which gut mic
Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Re 0.804 neurodegeneration What are the mechanisms by which gut mic
TREM2-mTOR Co-Agonism for Metabolic Reprogramming 0.803 neurodegeneration TREM2 agonism vs antagonism in DAM micro

Mentioning Analyses (30)

Scientific analyses that reference this entity

What are the mechanisms by which microglial senescence contributes to ALS pathol

neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.776

What mechanisms drive the self-amplifying vicious cycle linking oxidative stress

neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.760

Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.780

Can ferroptosis inhibitors prevent BBB disruption and edema formation after card

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.760

Which specific factors in conditioned medium from healthy astrocytes rescue moto

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.730

Experiments (7)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) in_progress N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
E2F coordination of G2/M transcriptional program exploratory 0.750 0.00 endocycling mammalian cells proposed N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.200 0.00 Mouse (5xFAD/TREM2-/-) in_progress N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia J Inflamm Res 2022 1
TREM2, microglia, and Alzheimer's disease. [PMID:33516818] Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Mech Ageing Dev 2021 1
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 1
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. [PMID:28802038] Ulland TK, Song WM, Huang SC, Ulrich JD, Cell 2017 1
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] Krasemann S, Madore C, Cialic R, Baufeld Immunity 2017 1
Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and T [PMID:41833042] ["Lyu G", "Li D"] CNS & neurological disorders d 2026 0
Emerging pathological mechanisms of Alzheimer's disease pathogenesis: from neuro [PMID:41858793] ["Wang R", "Feng Y", "Zhou Z", "Jiang J" Frontiers in aging neuroscienc 2026 0
Human CSF proteogenomics links genetic variation to neurodegenerative disease pr [PMID:41757182] ["Puerta R", "Garc\u00eda-Gonz\u00e1lez medRxiv : the preprint server 2026 0
PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907] Tsai AP, Martin AK, Mi A, Yeh AE, Ramire Molecular neurodegeneration 2026 0
PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907] Tsai AP, Martin AK, Mi A, Yeh AE, Ramire Mol Neurodegener 2026 0
TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604] Yang HC, Deng YS, Zhang J, Zhang T, Song J Alzheimers Dis 2026 0
Investigating the Potential of Gene Editing Technologies in Enhancing Stem Cell [PMID:41926312] ["Mehrabadi S"] Current aging science 2026 0
TREM2 in neurodegeneration and diseases. [PMID:41792456] ["Abdulkhaliq A", "Alasiri G", "Kim B", Molecular psychiatry 2026 0
Berbamine hydrochloride as a brain penetrant galectin 3 inhibitor in a model of [PMID:41772384] ["Siew J", "Lee C", "Chen H", "Lin H", " Brain : a journal of neurology 2026 0
The microglial TREM2 receptor programs hippocampal development in a mouse model [PMID:41887542] Ahmed S, Bowers C, Munoz-Martin J, Jamwa Brain, behavior, and immunity 2026 0
Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] Alhusaini M, Mussa BM, Ilce BY, Alhaj H, Frontiers in aging neuroscienc 2026 0
Oligodendrocyte precursor cells-microglia crosstalk via BMP4 drives microglial n [PMID:41881962] Baek S, Jang J, Yeo S, Jung HJ, Choe Y Signal transduction and target 2026 0
Phagocytes as plaque catalysts: Human macrophages generate seeding-competent Aβ4 [PMID:41770935] ["Konstantoulea K", "Ramakers M", "Borri Proceedings of the National Ac 2026 0
Microglia, Trem2, and Neurodegeneration. [PMID:38769824] Shi Q, Gutierrez RA, Bhat MA Neuroscientist 2025 0
Microglia, Trem2, and Neurodegeneration. [PMID:38769824] Shi Q, Gutierrez RA, Bhat MA The Neuroscientist : a review 2025 0

Debates (20)

Multi-agent debates referencing this entity

What are the mechanisms by which microglial senescence contributes to ALS pathol

active · Rounds: 6 · Score: 0.75 · 2026-04-26

What mechanisms drive the self-amplifying vicious cycle linking oxidative stress

active · Rounds: 4 · Score: 0.84 · 2026-04-25

Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?

active · Rounds: 4 · Score: 0.77 · 2026-04-25

Can ferroptosis inhibitors prevent BBB disruption and edema formation after card

active · Rounds: 4 · Score: 0.73 · 2026-04-25

Which specific factors in conditioned medium from healthy astrocytes rescue moto

active · Rounds: 4 · Score: 0.65 · 2026-04-25

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

active · Rounds: 4 · Score: 0.66 · 2026-04-25

How does lncRNA-0021 achieve sequence-specific binding to mmu-miR-6361 and what

active · Rounds: 4 · Score: 0.66 · 2026-04-25

Which specific CSF molecular components are essential for maintaining disease-re

active · Rounds: 4 · Score: 0.66 · 2026-04-25

Which specific transcription factors mediate MAPT suppression during proteostati

active · Rounds: 4 · Score: 0.66 · 2026-04-25

What specific autophagy pathways are defective in radiation-induced pericyte sen

active · Rounds: 4 · Score: 0.66 · 2026-04-25

Related Research

Hypotheses and analyses mentioning 2 in their description or question text

HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM Transition

Score: 0.919 · neurodegeneration · 2026-04-16

## Mechanistic Overview HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM Transition starts from the claim tha

TREM2-ASM Crosstalk in Microglial Lysosomal Senescence

Score: 0.910 · neurodegeneration · 2026-04-12

## Mechanistic Overview TREM2-ASM Crosstalk in Microglial Lysosomal Senescence starts from the claim that modulating SMP

TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegeneration

Score: 0.907 · neurodegeneration · 2026-04-12

## Mechanistic Overview TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegeneration starts from the claim that mo

SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence

Score: 0.895 · neurodegeneration · 2026-04-12

## Mechanistic Overview SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence starts from the claim that modu

TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration

Score: 0.892 · neurodegeneration · 2026-04-07

## Mechanistic Overview TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration starts from the claim that mod

H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to A

Score: 0.887 · neurodegeneration · 2026-04-14

## Mechanistic Overview H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to Amyloid Clearance

TREM2-APOE Axis Dissociation for Selective DAM Activation

Score: 0.886 · neurodegeneration · 2026-04-16

## Mechanistic Overview TREM2-APOE Axis Dissociation for Selective DAM Activation starts from the claim that modulating

TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegeneration

Score: 0.880 · neurodegeneration · 2026-04-07

## **Molecular Mechanism and Rationale** The triggering receptor expressed on myeloid cells 2 (TREM2) serves as a criti

TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegeneration

Score: 0.875 · neurodegeneration · 2026-04-07

**Molecular Mechanism and Rationale** The TREM2-mediated astrocyte-microglia cross-talk mechanism represents a complex

TREM2-Mediated Cholesterol Dysregulation in Microglial Senescence

Score: 0.869 · neurodegeneration · 2026-04-07

## Mechanistic Overview TREM2-Mediated Cholesterol Dysregulation in Microglial Senescence starts from the claim that mod

GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance

Score: 0.869 · neuroscience · 2026-04-12

## Mechanistic Overview GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance starts from the claim that m

Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stab

Score: 0.861 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization starts

TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Faile

Score: 0.858 · neurodegeneration · 2026-04-16

## Mechanistic Overview TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Transition

Microglial Senescence Prevention via TREM2/SASP Axis

Score: 0.847 · neurodegeneration · 2026-04-17

## Mechanistic Overview Microglial Senescence Prevention via TREM2/SASP Axis starts from the claim that modulating not y

TYROBP (DAP12) Conditional Antagonism for Early-Stage Neuroprotection

Score: 0.844 · neurodegeneration · 2026-04-16

## Mechanistic Overview TYROBP (DAP12) Conditional Antagonism for Early-Stage Neuroprotection starts from the claim that